Minondas, Stieven Jhon R.

HRN: 10-05-77  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/06/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/06/2023
03/12/2023
IV
165mg
Q12
Typhoid
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: